SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
|
Jun. 04, 2019
USD ($)
facility
|
Jun. 30, 2019
USD ($)
|
Jun. 30, 2018
USD ($)
|
Jun. 30, 2019
USD ($)
|
Jun. 30, 2018
USD ($)
|
Dec. 31, 2018
USD ($)
|
|
| Accounting Policies [Abstract] | ||||||
| Accumulated deficit | $ 120,729,000 | $ 120,729,000 | $ 115,091,000 | |||
| Impairment charges, finite-lived | 0 | $ 0 | 0 | $ 0 | ||
| Impairment charges, indefinite-lived | 0 | 0 | 0 | 0 | ||
| Research and development costs | 1,234,000 | $ 1,115,000 | 2,447,000 | $ 2,333,000 | ||
| Business Acquisition [Line Items] | ||||||
| Operating lease right-of-use asset | 75,000 | 75,000 | ||||
| Operating lease liability | 75,000 | 75,000 | ||||
| Orthex | ||||||
| Business Acquisition [Line Items] | ||||||
| Operating lease right-of-use asset | $ 77,000,000 | 75,000,000 | 75,000,000 | |||
| Operating lease liability | $ 75,000,000 | $ 75,000,000 | ||||
| Vilex | ||||||
| Business Acquisition [Line Items] | ||||||
| Operating lease liability | $ 246,000,000 | |||||
| Vilex and Orthex | ||||||
| Business Acquisition [Line Items] | ||||||
| Number of facilities acquired | facility | 2 | |||||